1. Home
  2. MIMI vs LXRX Comparison

MIMI vs LXRX Comparison

Compare MIMI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIMI
  • LXRX
  • Stock Information
  • Founded
  • MIMI 2018
  • LXRX 1995
  • Country
  • MIMI Hong Kong
  • LXRX United States
  • Employees
  • MIMI N/A
  • LXRX N/A
  • Industry
  • MIMI
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIMI
  • LXRX Health Care
  • Exchange
  • MIMI NYSE
  • LXRX Nasdaq
  • Market Cap
  • MIMI 139.9M
  • LXRX 124.4M
  • IPO Year
  • MIMI 2025
  • LXRX 2000
  • Fundamental
  • Price
  • MIMI $3.95
  • LXRX $0.51
  • Analyst Decision
  • MIMI
  • LXRX Buy
  • Analyst Count
  • MIMI 0
  • LXRX 4
  • Target Price
  • MIMI N/A
  • LXRX $3.67
  • AVG Volume (30 Days)
  • MIMI 181.2K
  • LXRX 32.2M
  • Earning Date
  • MIMI 01-01-0001
  • LXRX 05-01-2025
  • Dividend Yield
  • MIMI N/A
  • LXRX N/A
  • EPS Growth
  • MIMI N/A
  • LXRX N/A
  • EPS
  • MIMI 0.04
  • LXRX N/A
  • Revenue
  • MIMI $4,248,548.00
  • LXRX $31,081,000.00
  • Revenue This Year
  • MIMI N/A
  • LXRX N/A
  • Revenue Next Year
  • MIMI N/A
  • LXRX $63.36
  • P/E Ratio
  • MIMI $111.08
  • LXRX N/A
  • Revenue Growth
  • MIMI 63.94
  • LXRX 2481.48
  • 52 Week Low
  • MIMI $3.36
  • LXRX $0.28
  • 52 Week High
  • MIMI $6.84
  • LXRX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • MIMI N/A
  • LXRX 53.30
  • Support Level
  • MIMI N/A
  • LXRX $0.48
  • Resistance Level
  • MIMI N/A
  • LXRX $0.60
  • Average True Range (ATR)
  • MIMI 0.00
  • LXRX 0.09
  • MACD
  • MIMI 0.00
  • LXRX 0.01
  • Stochastic Oscillator
  • MIMI 0.00
  • LXRX 42.86

About MIMI MINT INCORPORATION LIMITED

Mint Inc Ltd is a Hong Kong-based interior design and fit-out works provider. It strategically focuses on providing integrated and industry-specific interior design and fit-out works for commercial properties. The company's work encompasses offices of different industries and various kinds of retail stores to reflect its customers' corporate values and conceptualize its customers' brands. Its commercial projects cover internationally-renowned retail stores, food and beverage outlet chains, offices, and other premises of a charitable organization in Hong Kong. It also provides integrated interior design and fit-out works for luxury residential properties to enhance the interior space's aesthetics and functionality.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Share on Social Networks: